Giving AXL the axe: targeting AXL in human malignancy

por Gay, Carl M, Balaji, Kavitha, Byers, Lauren Averett
Publicado 2017

Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers

por Cardnell, Robert J., Byers, Lauren Averett, Wang, Jing
Publicado 2019

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer

por Della Corte, Carminia Maria, Gay, Carl Michael, Byers, Lauren Averett, Morgillo, Floriana
Publicado 2018

Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream Analysis

por Tong, Pan, Diao, Lixia, Shen, Li, Li, Lerong, Heymach, John Victor, Girard, Luc, Minna, John D., Coombes, Kevin R., Byers, Lauren Averett, Wang, Jing
Publicado 2016

A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase Inhibitors

por Iommelli, Francesca, De Rosa, Viviana, Terlizzi, Cristina, Fonti, Rosa, Camerlingo, Rosa, Stoppelli, Maria Patrizia, Stewart, C. Allison, Byers, Lauren Averett, Piwnica-Worms, David, Del Vecchio, Silvana
Publicado 2021

Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma

por Park, Yun-Yong, Park, Eun Sung, Kim, Sang Bae, Kim, Sang Cheol, Sohn, Bo Hwa, Chu, In-Sun, Jeong, Woojin, Mills, Gordon B., Byers, Lauren Averett, Lee, Ju-Seog
Publicado 2012

A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients

por Byers, Lauren Averett, Horn, Leora, Ghandi, Jitendra, Kloecker, Goetz, Owonikoko, Taofeek, Waqar, Saiama Naheed, Krzakowski, Maciej, Cardnell, Robert J., Fujimoto, Junya, Taverna, Pietro, Azab, Mohammad, Camidge, David Ross
Publicado 2017

BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

por Nelson, Blessie Elizabeth, Roszik, Jason, Janku, Filip, Hong, David S., Kato, Shumei, Naing, Aung, Piha-Paul, Sarina, Fu, Siqing, Tsimberidou, Apostolia, Cabanillas, Maria, Busaidy, Naifa Lamki, Javle, Milind, Byers, Lauren Averett, Heymach, John V., Meric-Bernstam, Funda, Subbiah, Vivek
Publicado 2023

Identification and Characterization of a Suite of Tumor Targeting Peptides for Non-Small Cell Lung Cancer

por McGuire, Michael J., Gray, Bethany Powell, Li, Shunzi, Cupka, Dorothy, Byers, Lauren Averett, Wu, Lei, Rezaie, Shaghayegh, Liu, Ying-Horng, Pattisapu, Naveen, Issac, James, Oyama, Tsukasa, Diao, Lixia, Heymach, John V., Xie, Xian-Jin, Minna, John D., Brown, Kathlynn C.
Publicado 2014

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung...

por Gomez, Daniel Richard, Byers, Lauren Averett, Nilsson, Monique, Diao, Lixia, Wang, Jing, Li, Lerong, Tong, Pan, Hofstad, Mia, Saigal, Babita, Wistuba, Ignacio, Kalhor, Neda, Swisher, Stephen, Fan, Youhong, Hong, Waun Ki, Suraokar, Milind, Behrens, Carmen, Moran, Cesar, Heymach, John Victor
Publicado 2018

Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters

por He, Yong, Zhou, Zhen, Hofstetter, Wayne L., Zhou, Yanbin, Hu, Wenxian, Guo, Chengcheng, Wang, Li, Guo, Wei, Pataer, Apar, Correa, Arlene M., Lu, Yiling, Wang, Jing, Diao, Lixia, Byers, Lauren Averett, Wistuba, Ignacio I., Roth, Jack A., Swisher, Stephen G., Heymach, John V., Fang, Bingliang
Publicado 2012

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study

por Ramalingam, Suresh S., Novello, Silvia, Guclu, Salih Zeki, Bentsion, Dmitry, Zvirbule, Zanete, Szilasi, Maria, Bernabe, Reyes, Syrigos, Konstantinos, Byers, Lauren Averett, Clingan, Philip, Bar, Jair, Vokes, Everett E., Govindan, Ramaswamy, Dunbar, Martin, Ansell, Peter, He, Lei, Huang, Xin, Sehgal, Vasudha, Glasgow, Jaimee, Bach, Bruce A., Mazieres, Julien
Publicado 2021

Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC

por Della Corte, Carminia Maria, Ciaramella, Vincenza, Ramkumar, Kavya, Vicidomini, Giovanni, Fiorelli, Alfonso, Nardone, Valerio, Cappabianca, Salvatore, Cozzolino, Immacolata, Zito Marino, Federica, Di Guida, Gaetano, Wang, Qi, Cardnell, Robert, Gay, Carl Michael, Ciardiello, Davide, Martinelli, Erika, Troiani, Teresa, Martini, Giulia, Napolitano, Stefania, Wang, Jing, Byers, Lauren Averett, Ciardiello, Fortunato, Morgillo, Floriana
Publicado 2022

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

por Stewart, C. Allison, Tong, Pan, Cardnell, Robert J., Sen, Triparna, Li, Lerong, Gay, Carl M., Masrorpour, Fatemah, Fan, You, Bara, Rasha O., Feng, Ying, Ru, Yuanbin, Fujimoto, Junya, Kundu, Samrat T., Post, Leonard E., Yu, Karen, Shen, Yuqiao, Glisson, Bonnie S., Wistuba, Ignacio, Heymach, John V., Gibbons, Don L., Wang, Jing, Byers, Lauren Averett
Publicado 2017

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

por Pietanza, M. Catherine, Waqar, Saiama N., Krug, Lee M., Dowlati, Afshin, Hann, Christine L., Chiappori, Alberto, Owonikoko, Taofeek K., Woo, Kaitlin M., Cardnell, Robert J., Fujimoto, Junya, Long, Lihong, Diao, Lixia, Wang, Jing, Bensman, Yevgeniva, Hurtado, Brenda, de Groot, Patricia, Sulman, Erik P., Wistuba, Ignacio I., Chen, Alice, Fleisher, Martin, Heymach, John V., Kris, Mark G., Rudin, Charles M., Byers, Lauren Averett
Publicado 2018

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

por Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
Publicado 2021

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

por Stewart, C. Allison, Gay, Carl M., Ramkumar, Kavya, Cargill, Kasey R., Cardnell, Robert J., Nilsson, Monique B., Heeke, Simon, Park, Elizabeth M., Kundu, Samrat T., Diao, Lixia, Wang, Qi, Shen, Li, Xi, Yuanxin, Zhang, Bingnan, Della Corte, Carminia Maria, Fan, Youhong, Kundu, Kiran, Gao, Boning, Avila, Kimberley, Pickering, Curtis R., Johnson, Faye M., Zhang, Jianjun, Kadara, Humam, Minna, John D., Gibbons, Don L., Wang, Jing, Heymach, John V., Byers, Lauren Averett
Publicado 2021

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

por Cascone, Tina, Leung, Cheuk H., Weissferdt, Annikka, Pataer, Apar, Carter, Brett W., Godoy, Myrna C. B., Feldman, Hope, William, William N., Xi, Yuanxin, Basu, Sreyashi, Sun, Jing Jing, Yadav, Shalini S., Rojas Alvarez, Frank R., Lee, Younghee, Mishra, Aditya K., Chen, Lili, Pradhan, Monika, Guo, Haiping, Sinjab, Ansam, Zhou, Nicolas, Negrao, Marcelo V., Le, Xiuning, Gay, Carl M., Tsao, Anne S., Byers, Lauren Averett, Altan, Mehmet, Glisson, Bonnie S., Fossella, Frank V., Elamin, Yasir Y., Blumenschein, George, Zhang, Jianjun, Skoulidis, Ferdinandos, Wu, Jia, Mehran, Reza J., Rice, David C., Walsh, Garrett L., Hofstetter, Wayne L., Rajaram, Ravi, Antonoff, Mara B., Fujimoto, Junya, Solis, Luisa M., Parra, Edwin R., Haymaker, Cara, Wistuba, Ignacio I., Swisher, Stephen G., Vaporciyan, Ara A., Lin, Heather Y., Wang, Jing, Gibbons, Don L., Jack Lee, J., Ajami, Nadim J., Wargo, Jennifer A., Allison, James P., Sharma, Padmanee, Kadara, Humam, Heymach, John V., Sepesi, Boris
Publicado 2023